Tanglewood Legacy Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Buy
12,210
+78
+0.6% +$9.01K 0.53% 34
2025
Q4
$1.28M Buy
12,132
+150
+1% +$14.1K 0.48% 36
2025
Q3
$1.01M Sell
11,982
-141
-1% -$11.6K 0.39% 39
2025
Q2
$960K Hold
12,123
0.39% 40
2025
Q1
$1.09M Hold
12,123
0.48% 32
2024
Q4
$1.21M Hold
12,123
0.52% 34
2024
Q3
$1.38M Hold
12,123
0.61% 29
2024
Q2
$1.5M Hold
12,123
0.71% 23
2024
Q1
$1.6M Hold
12,123
0.79% 22
2023
Q4
$1.32M Hold
12,123
0.72% 22
2023
Q3
$1.25M Hold
12,123
0.75% 22
2023
Q2
$1.4M Hold
12,123
0.81% 21
2023
Q1
$1.29M Hold
12,123
0.82% 20
2022
Q4
$1.35M Buy
+12,123
New +$1.24M 0.96% 19

Other funds holding MRK

Tanglewood Legacy Advisors's MRK Position: Q1 2026 in Review

Tanglewood Legacy Advisors increased its Merck (MRK) stake by 0.64% in Q1 2026, buying an estimated $9.01K and bringing the position to 12,210 shares worth $1.47M. The position accounts for 0.53% of the portfolio, ranked #34.

Tanglewood Legacy Advisors first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.6M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Tanglewood Legacy Advisors held 12,210 shares of Merck worth $1.47M as of Q1 2026.
  • Tanglewood Legacy Advisors bought 78 Merck shares in Q1 2026, an estimated $9.01K.
  • Merck made up 0.53% of Tanglewood Legacy Advisors's portfolio in Q1 2026, its #34 holding.
  • Tanglewood Legacy Advisors first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Tanglewood Legacy Advisors's Merck position peaked at $1.6M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Tanglewood Legacy Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.